Sustained-release drug delivery systems for the treatment of glaucoma

Sustained-release drug delivery systems for the treatment of glaucoma

Glaucoma, a leading cause of irreversible blindness, affects more than 64 million people worldwide and is expected to grow in number due to the aging global population and enhanced methods of detection. Although topical therapies are often effective when used as prescribed, the drawbacks of current...

Full description

Bibliographic Details
Main Authors: Natasha P. Kesav, Cara E. Capitena Young, Monica K. Ertel, Leonard K. Seibold, Malik Y. Kahook
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2021-01-01
Series:International Journal of Ophthalmology
Subjects:
glaucoma
drug delivery
sustained release
Online Access:http://ies.ijo.cn/en_publish/2021/1/20210121.pdf

Similar Items

Similar Items